[1]
|
Katan, M. and Luft, A. (2018) Global Burden of Stroke. Seminars in Neurology, 38, 208-211.
https://doi.org/10.1055/s-0038-1649503
|
[2]
|
贾建平. 神经病学[M]. 第8版. 北京: 人民卫生出版社, 2018: 190-191.
|
[3]
|
Kamstrup, P.R. (2021) Lipoprotein(a) and Cardiovascular Disease. Clinical Chemistry, 67, 154-166.
https://doi.org/10.1093/clinchem/hvaa247
|
[4]
|
脂蛋白(a)与心血管疾病风险关系及临床管理的专家科学建议[J]. 中国循环杂志, 2021, 36(12): 1158-1167.
|
[5]
|
Afshar, M. and Thanassoulis, G. (2017) Lipoprotein(a): New In-sights from Modern Genomics. Current Opinion in Lipidology, 28, 170-176. https://doi.org/10.1097/MOL.0000000000000392
|
[6]
|
Reyes-Soffer, G. and Westerterp, M. (2021) Beyond Lipo-protein(a) Plasma Measurements: Lipoprotein(a) and Inflammation. Pharmacological Research, 169, Article ID: 105689. https://doi.org/10.1016/j.phrs.2021.105689
|
[7]
|
Kronenberg, F., Mora, S., Stroes, E.S.G., et al. (2022) Lipopro-tein(a) in Atherosclerotic Cardiovascular Disease and Aortic Stenosis: A European Atherosclerosis Society Consensus Statement. European Heart Journal, 43, 3925-3946.
https://doi.org/10.1093/eurheartj/ehac361
|
[8]
|
Kronenberg, F. (2014) Lipoprotein(a) in Various Conditions: To Keep a Sense of Proportions. Atherosclerosis, 234, 249-251. https://doi.org/10.1016/j.atherosclerosis.2014.01.054
|
[9]
|
Kronenberg, F. (2022) Lipoprotein(a). In: von Eckard-stein, A. and Binder, C.J., Eds., Prevention and Treatment of Atherosclerosis, Handbook of Experimental Pharmacology, Vol. 270, Springer, Cham, 201-232.
https://doi.org/10.1007/164_2021_504
|
[10]
|
Coassin, S., Erhart, G., Weissensteiner, H., et al. (2017) A Novel but Frequent Variant in LPA KIV-2 Is Associated with a Pronounced Lp(a) and Cardiovascular Risk Reduction. European Heart Journal, 38, 1823-1831.
https://doi.org/10.1093/eurheartj/ehx174
|
[11]
|
Hopewell, J.C., Haynes, R. and Baigent, C. (2018) The Role of Lip-oprotein (a) in Chronic Kidney Disease. Journal of Lipid Research, 59, 577-585. https://doi.org/10.1194/jlr.R083626
|
[12]
|
Kronenberg, F. (2014) Causes and Consequences of Lipoprotein(a) Ab-normalities in Kidney Disease. Clinical and Experimental Nephrology, 18, 234-237. https://doi.org/10.1007/s10157-013-0875-8
|
[13]
|
Simony, S.B., Mortensen, M.B., Langsted, A., Afzal, S., Kam-strup, P.R. and Nordestgaard, B.G. (2022) Sex Differences of Lipoprotein(a) Levels and Associated Risk of Morbidity and Mortality by Age: The Copenhagen General Population Study. Atherosclerosis, 355, 76-82. https://doi.org/10.1016/j.atherosclerosis.2022.06.1023
|
[14]
|
Paré, G., Çak, A., McQueen, M., et al. (2019) Lipo-protein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups. Circulation, 139, 1472-1482. https://doi.org/10.1161/CIRCULATIONAHA.118.034311
|
[15]
|
Enkhmaa, B. and Berglund, L. (2022) Non-Genetic Influences on Lipoprotein(a) Concentrations. Atherosclerosis, 349, 53-62. https://doi.org/10.1016/j.atherosclerosis.2022.04.006
|
[16]
|
Milionis, H.J., Elisaf, M.S., Tselepis, A., Bairaktari, E., Karabina, S.A. and Siamopoulos, K.C. (1999) Apolipoprotein(a) Phenotypes and Lipoprotein(a) Concentrations in Pa-tients with Renal Failure. American Journal of Kidney Diseases, 33, 1100-1106. https://doi.org/10.1016/S0272-6386(99)70147-2
|
[17]
|
Gregory, W.L., Game, F.L., Farrer, M., Idle, J.R., Laker, M.F. and James, O.F. (1994) Reduced Serum Lipoprotein(a) Levels in Patients with Primary Biliary Cirrhosis. Athero-sclerosis, 105, 43-50.
https://doi.org/10.1016/0021-9150(94)90006-X
|
[18]
|
Wilson, D.P., Jacobson, T.A., Jones, P.H., et al. (2022) Use of Lipoprotein(a) in Clinical Practice: A Biomarker Whose Time Has Come. A Scientific Statement from the National Li-pid Association. Journal of Clinical Lipidology, 16, e77-e95.
https://doi.org/10.1016/j.jacl.2022.08.007
|
[19]
|
冯仁丰. 脂蛋白(a)检测的标准化[J]. 检验医学, 2017, 32(7): 555-560.
|
[20]
|
Marcovina, S.M. and Albers, J.J. (2016) Lipoprotein (a) Measurements for Clinical Application. Journal of Lipid Research, 57, 526-537. https://doi.org/10.1194/jlr.R061648
|
[21]
|
Rigal, M., Ruidavets, J. B., Viguier, A., Petit, R., Perret, B., Ferrieres, J. and Larrue, V. (2007) Lipoprotein (a) and Risk of Ischemic Stroke in Young Adults. Journal of the Neurological Sciences, 252, 39-44.
https://doi.org/10.1016/j.jns.2006.10.004
|
[22]
|
Zhang, J., Du, R., Peng, K., et al. (2019) Serum Lipoprotein (a) Is Associated with Increased Risk of Stroke in Chinese Adults: A Prospective Study. Atherosclerosis, 289, 8-13. https://doi.org/10.1016/j.atherosclerosis.2019.07.025
|
[23]
|
Langsted, A., Nordestgaard, B.G. and Kamstrup, P.R. (2019) Elevated Lipoprotein(a) and Risk of Ischemic Stroke. Journal of the American College of Cardiology, 74, 54-66. https://doi.org/10.1016/j.jacc.2019.03.524
|
[24]
|
Kumar, P., Swarnkar, P., Misra, S. and Nath, M. (2021) Lipopro-tein (a) Level as a Risk Factor for Stroke and Its Subtype: A Systematic Review and Meta-Analysis. Scientific Reports, 11, Article No. 15660.
https://doi.org/10.1038/s41598-021-95141-0
|
[25]
|
Lange, K.S., Nave, A.H., Liman, T.G., Grittner, U., Endres, M. and Ebinger, M. (2017) Lipoprotein(a) Levels and Recurrent Vascular Events After First Ischemic Stroke. Stroke, 48, 36-42.
https://doi.org/10.1161/STROKEAHA.116.014436
|
[26]
|
Arnold, M., Schweizer, J., Nakas, C.T., et al. (2021) Lipoprotein(a) Is Associated with Large Artery Atherosclerosis Stroke Aetiology and Stroke Recurrence among Patients Below the Age of 60 Years: Results from the Biosignal Study. European Heart Journal, 42, 2186-2196. https://doi.org/10.1093/eurheartj/ehab081
|
[27]
|
van Dam-Nolen, D.H.K., van Dijk, A.C., Crombag, G.A.J.C., et al. (2021) Lipoprotein(a) Levels and Atherosclerotic Plaque Characteristics in the Carotid Artery: The Plaque at RISK (PARISK) Study. Atherosclerosis, 329, 22-29.
https://doi.org/10.1016/j.atherosclerosis.2021.06.004
|
[28]
|
Kim, B.S., Jung, H.S., Bang, O.Y., Chung, C.S., Lee, K.H. and Kim, G.M. (2010) Elevated Serum Lipoprotein(a) as a Potential Predictor for Combined Intracranial and Extra-cranial Artery Stenosis in Patients with Ischemic Stroke. Atherosclerosis, 212, 682-688. https://doi.org/10.1016/j.atherosclerosis.2010.07.007
|
[29]
|
Tsimikas, S., Gordts, P.L.S.M., Nora, C., Yeang, C. and Witztum, J.L. (2020) Statin Therapy Increases Lipoprotein(a) Levels. European Heart Journal, 41, 2275-2284. https://doi.org/10.1093/eurheartj/ehz310
|
[30]
|
Sahebkar, A., Simental-Mendía L.E., Watts, G.F., et al. (2017) Com-parison of the Effects of Fibrates Versus Statins on Plasma Lipoprotein(a) Concentrations: A Systematic Review and Meta-Analysis of Head-to-Head Randomized Controlled Trials. BMC Medicine, 15, Article No. 22. https://doi.org/10.1186/s12916-017-0787-7
|
[31]
|
Gaeta, G., Lanero, S., Barra, S., Silvestri, N., Cuomo, V., Ma-terazzi, C. and Vitagliano, G. (2011) Sex Hormones and Lipoprotein(a) Concentration. Expert Opinion on Investigational Drugs, 20, 221-238.
https://doi.org/10.1517/13543784.2011.548804
|
[32]
|
Langsted, A. and Nordestgaard, B.G. (2019) Antisense Oli-gonucleotides Targeting Lipoprotein(a). Current Atherosclerosis Reports, 21, Article No. 30. https://doi.org/10.1007/s11883-019-0792-8
|
[33]
|
Cao, Y.X., Liu, H.H., Li, S., et al. (2019) A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) Levels. American Journal of Cardiovascular Drugs, 19, 87-97.
https://doi.org/10.1007/s40256-018-0303-2
|
[34]
|
Sahebkar, A., Simental-Mendía, L.E., Stefanutti, C., et al. (2016) Supplementation with Coenzyme Q10 Reduces Plasma Lipoprotein(a) Concentrations but Not other Lipid Indices: A Systematic Review and Meta-Analysis. Pharmacological Research, 105, 198-209. https://doi.org/10.1016/j.phrs.2016.01.030
|
[35]
|
Schettler, V.J.J., Neumann, C.L., Peter, C., Zimmermann, T., Julius, U., Hohenstein, B., et al. (2019) Lipoprotein Apheresis Is an Optimal Therapeutic Option to Reduce Increased Lp(a) Levels. Clinical Research in Cardiology Supplements, 14, 33-38. https://doi.org/10.1007/s11789-019-00094-4
|
[36]
|
Marcovina, S.M. and Shapiro, M.D. (2022) Measurement of Lipoprotein(a): A Once in a Lifetime Opportunity. Journal of the American College of Cardiology, 79, 629-631. https://doi.org/10.1016/j.jacc.2021.11.053
|